Results 161 to 170 of about 2,977,193 (214)
Palmoplantar pustulosis: pathogenesis, differential diagnosis, and treatment. [PDF]
Mössner R +5 more
europepmc +1 more source
Perianal squamous cell carcinoma in the absence of HPV or immunosuppression: A rare case report. [PDF]
Doan V +3 more
europepmc +1 more source
High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome.
Weiner JD +5 more
europepmc +1 more source
Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy
The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
R G Panizzon, R G Panizzon
exaly +6 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Documenta Ophthalmologica, 1983
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
Successful Treatment of Scleroderma With PUVA Therapy
Journal of Dermatology, 1996AbstractPUVA therapy was carried out on four patients with scleroderma; three of them had cutaneous manifestations of progressive systemic sclerosis and one other exhibited generalized morphea. PUVA therapy was given with daily doses of 0.25 J/cm2 or 0.4 J/cm2 for 3–8 weeks, resulting in total doses between 3.5 J/cm2 and 9.6 J/cm2.
Shigeto Matsushita +2 more
exaly +3 more sources
Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
OCULAR COMPLICATIONS OF PUVA THERAPY
Australasian Journal of Dermatology, 1993SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
J A, See, P, Weller
openaire +2 more sources
Melanoma After PUVA Therapy for Psoriasis
New England Journal of Medicine, 1997W L Morison, S E Whitmore
exaly +3 more sources

